MarketPeel
Insider Trading Intelligence
FF

Foundation Fighting Blindness Retinal Degeneration Fund

IRD
DIRECTOR · OPUS GENETICS, INC. · CIK 0002042266
FILING MIX · LIFETIME25%/75%
BUYS
1
SELLS
3
TOTAL VALUE
$15.99M
COMPANIES
1
ACTIVE SINCE
May 2025
HOLDINGS NOW
3,792,171
AVG SELL PX
$2.81
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Foundation Fighting Blindness Retinal Degeneration Fund, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-10.46%-0.61%-9.85%-9.85%
14d1+100.00%-15.90%+0.72%-16.62%-16.62%
30d1+100.00%-16.32%+0.95%-17.27%-17.27%
60d1+0.00%+25.94%+1.11%+24.83%+24.83%
90d1+0.00%+99.58%-0.70%+100.28%+100.28%
180d1+0.00%+68.62%+7.96%+60.66%+60.66%
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IRD · 3,792,171 shares · as of May 18, 2026
02,373,0434,746,0867,119,1289,492,1712026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2026
2026
FLOW · 1 buys / 3 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IRD
OPUS GENETICS, INC.
SALE
1,700,000$4.35$7.39M3,792,171May 18, 2026May 20, 2026View →
IRD
OPUS GENETICS, INC.
SALE
4,000,000$2.15$8.60M5,492,171Dec 9, 2025Dec 11, 2025View →
IRD
OPUS GENETICS, INC.
PURCHASE
6,927,4199,492,171May 5, 2025May 6, 2025View →
IRD
OPUS GENETICS, INC.
SALE
6,927.4190May 5, 2025May 6, 2025View →
Other insiders · IRD
Loading peer insiders…
About this filer
CIK 0002042266
ROLE
Director
PRIMARY
IRD
COMPANIES
1
ACTIVE SINCE
May 2025
MARKETPEEL · /INSIDER/0002042266DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback